52Falabella,A.F.Debridementand
woundbedpreparation.Dermatol
Ther.2006;19:317–325.
53Pullen,R.,Popp,R.,Volkers,P.,
Fusgen,I.Prospectiverandomized
double-blindstudyofthewound-
debridingeffectsofcollagenaseand
fibrinolysin/deoxyribonucleasein
pressureulcers.AgeAgeing.2002;
31:126–130.
54Ramundo,J.,Gray,M.Collagenase
forenzymaticdebridement:a
systematicreview.JWoundOstomy
ContinenceNurs.2009;36:4–11.
55Shapira,E.,Giladi,A.,Neiman,Z.
Useofwaterinsolublepapainfor
debridementofburnescharand
necrotictissue.PlastReconstrSurg.
2005;52:279.
56Hellgren,L.,Mohr,V.,Vincent,
J.ProteasesofAntarctickrill—a
newsystemforeffectiveenzymatic
debridementofnecroticulcerations.
Experientia.1986;42:403–404.
57Mekkes,J.R.,LePoole,I.C.,Das,P.K.
etal.Efficientdebridementofnecrotic
woundsusingproteolyticenzymes
derivedfromAntarctickrill:adouble-
blind,placebo-controlledstudyina
standardizedanimalwoundmodel.
WoundRepairRegen.1998;6:50–57.
58Dissemond,J.,Goos,M.
Conditioningofchronicwoundswith
proteolyticenzymes[inGerman].
Hautarzt.2003;54:1073–1079
59Smith,R.G.Enzymaticdebriding
agents:anevaluationofthemedical
literature.OstomyWoundManage.
2008;54:8,16–34.
60Goode,A.W.,Glazer,G.,Ellis,
B.W.Thecosteffectivenessof
DextranomerandEusolinthe
treatmentofinfectedsurgical
wounds.BrJClinPract.1979;33:
325–328.
61Heel,R.C.,Marton,P.,Brogden,
R.N.etal.Dextranomer:areviewof
itsgeneralpropertiesandtherapeutic
efficacy.Drugs.1979;18:89–102.
62Dissemond,J.,Goos,M.Options
fordebridementinthetherapy
ofchronicwounds[inGerman].
JDtschDermatolGes.2004;2:
743–751.
Dostları ilə paylaş: |